Lennard, T W <br/><br/>
A phase I study of immunostimulation and toxicity in patients with colorectal carcinoma using the immunomodulator 3,6-bis(2-piperidinoethoxy) acridine trihydrochloride (CL 246738).  [electronic resource] 

 -  European journal of cancer & clinical oncology  Nov 1989 
 - 1571-6 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0277-5379 
<br/><br/><label>Standard No.: </label>10.1016/0277-5379(89)90299-x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acridines--adverse effects<br/>Adenocarcinoma--drug therapy<br/>Adjuvants, Immunologic--adverse effects<br/>Adult<br/>Aged<br/>Antineoplastic Agents--adverse effects<br/>Colorectal Neoplasms--drug therapy<br/>Drug Evaluation<br/>Female<br/>Humans<br/>Male<br/>Middle Aged